Table 2.
Baseline characteristics of NVX-CoV2373 recipients, stratified by age groups.
| Characteristic | Age 12–35 (n = 78) |
Age 36–59 (n = 245) |
Age ≥ 60 (n = 274) |
|---|---|---|---|
| Age, median (IQR) years | 28 (23–33) | 49 (43–56) | 74 (67–82) |
| Gender, % | |||
| Female | 53 | 58 | 51 |
| Male | 47 | 42 | 49 |
| Unknown | 0 | 0 | NA |
| Median follow-up, months (IQR) | 8 (6–9) | 7 (6–8) | 4 (2–8) |
| Treating physician, % | |||
| General practitioner | 72 | 73 | 91 |
| Specialist | 28 | 27 | 9 |
| Geographical region, % | |||
| East Germany | 40 | 50 | 67 |
| West Germany | 60 | 50 | 33 |
| STIKO high-risk group, % | 24 | 45 | 100 |
| Age ≥ 60 years | – | – | 100 |
| Age ≥ 18 years + comorbidity | 24 | 45 | 68 |
| Care-facility resident | 0 | 0 | 7 |
COVID-19, coronavirus disease 2019; IQR, interquartile range; SD, standard deviation; STIKO, Standing Committee on Vaccination.